Skip to content
value.today

Achaogen Inc

Formerly VVII NewCo 2003, Inc.

Total raised
$90 M
4 rounds on record
Latest round
$10 M
May 2017
First round on record
Apr 2010
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Achaogen Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2017$10 MNo. 4$10 to $50 million

Achaogen Inc: Raise no. 4, May 2017

Investors in this round

1 investor had bought by the notice of May 16, 2017: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 16 investors are named for Achaogen Inc as a whole in other filings: see Investors below.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Blake W. Wise · Executive Officer
  • Gary W. Loeb · Executive Officer
  • Kenneth J. Hillan · Executive Officer, Director
  • Lee C. Swem · Executive Officer
  • Tobin C. Schilke · Executive Officer
  • Alan B. Colowick · Director
  • Bryan E. Roberts · Director
  • Gregory W. Stea · Director
  • Halley E. Gilbert · Director
  • John C. Doyle · Director
  • John W. Smither · Director
  • Kent E. Lieginger · Director
  • Michael C. Fischbach · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Tobin C. Schilke, Chief Financial Officer. Source: SEC Form D, newest notice filed May 16, 2017. Read the notice at the SEC.

equitySEC
Jun 2016$25 MNo. 3$10 to $50 million

Achaogen Inc: Raise no. 3, Jun 2016

Investors in this round

8 investors had bought by the notice of Jun 14, 2016: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 16 investors are named for Achaogen Inc as a whole in other filings: see Investors below.

What the notice says

Amount sold
$25 M of $33 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Blake R. Wise · Executive Officer
  • Ian R. Friedland · Executive Officer
  • Kenneth J. Hillan · Executive Officer, Director
  • Zeryn R. Sarpangal · Executive Officer
  • Alan B. Colowick · Director
  • Bryan E. Roberts · Director
  • Christopher T. Walsh · Director
  • Gregory W. Stea · Director
  • John C. Doyle · Director
  • John W. Smither · Director
  • Kent C. Lieginger · Director
  • Michael C. Fischbach · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Blake Wise, Chief Operating Officer. Source: SEC Form D, newest notice filed Jun 14, 2016. Read the notice at the SEC.

equity, optionsSEC
Mar 2013$19 MNo. 2$10 to $50 million

Achaogen Inc: Raise no. 2, Mar 2013

Investors in this round

15 investors had bought by the notice of Mar 22, 2013: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 16 investors are named for Achaogen Inc as a whole in other filings: see Investors below.

What the notice says

Amount sold
$19 M of $31 M offered; $12 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Becki J. Filice · Executive Officer
  • Christine J. Welch · Executive Officer
  • Dennis J. Hom · Executive Officer
  • Kenneth J. Hillan · Executive Officer, Director
  • Bryan J. Roberts · Director
  • Camille J. Samuels · Director
  • Christopher J. Walsh · Director
  • John J. Doyle · Director
  • Robert J. More · Director
  • Scott J. Rocklage · Director
  • Troy J. Cox · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark V. Roeder, Secretary. Source: SEC Form D, newest notice filed Mar 22, 2013. Read the notice at the SEC.

equitySEC
Apr 2010$35 MNo. 1$10 to $50 million

Achaogen Inc: Raise no. 1, Apr 2010

Investors in this round

15 investors had bought by the notice of Apr 19, 2010: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 16 investors are named for Achaogen Inc as a whole in other filings: see Investors below.

What the notice says

Amount sold
$35 M of $56 M offered; $21 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Heinz E. Moser · Executive Officer
  • J. Kevin Judice · Executive Officer, Director
  • John C. Doyle · Executive Officer
  • John F. Hollway · Executive Officer
  • Jon B. Bruss · Executive Officer
  • Bryan E. Roberts · Director
  • Camille D. Samuels · Director
  • Christopher D. Walsh · Director
  • Kenneth E. Nussbacher · Director
  • Robert D. More · Director
  • Scott E. Rocklage · Director
  • Thomas D. King · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by J. Kevin Judice, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 19, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Achaogen Inc chose not to state its revenue in its newest notice of a funding round (May 2017).

    SEC Form D · May 2017

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2017

That is all the official record says: Achaogen Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

16 named in official filings. Open an investor to see everything it has backed.

Investors in Achaogen Inc
InvestorKindAmountRoundRoleSource
Arch Venture Fund VI LPVenture capitalnot statednot statedHeld Series A, B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Arch Venture Partners VI LLCVenture capitalnot statednot statedHeld Series A, B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Arch Venture Partners VI LPVenture capitalnot statednot statedHeld Series A, B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Domain Parters VII L.P.Fund or asset managernot statednot statedHeld Series B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
DP VII Associates LPFund or asset managernot statednot statedHeld Series B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
VEF Management IV, LLCFund or asset managernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Venrock Associates IV L.P.Fund or asset managernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Venrock Entrepreneurs Fund IV L.P.Fund or asset managernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Venrock Management IV, LLCFund or asset managernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Venrock Partners, L.P.Fund or asset managernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Venrock Partners Management, LLCFund or asset managernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Versant Affiliates Fund II-A, LPFund or asset managernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Versant Side Fund II, LPFund or asset managernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Versant Venture Capital II, LPVenture capitalnot statednot statedHeld Series A, B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Versant Ventures II LLCVenture capitalnot statednot statedHeld Series A, B, C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3
WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUSTFund or asset managernot statednot statedHeld Series C and D preferred stock, 10% owner (Form 3, 2014)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 15 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Achaogen Inc
NameRoleNamed in
Blake W. WiseExecutive officerMay 2017
Gary W. LoebExecutive officerMay 2017
Kenneth J. HillanExecutive officerMay 2017
Lee C. SwemExecutive officerMay 2017
Tobin C. SchilkeExecutive officerMay 2017
Blake R. WiseExecutive officerJun 2016
Ian R. FriedlandExecutive officerJun 2016
Zeryn R. SarpangalExecutive officerJun 2016
Becki J. FiliceExecutive officerMar 2013
Christine J. WelchExecutive officerMar 2013
Dennis J. HomExecutive officerMar 2013
Heinz E. MoserExecutive officerApr 2010
J. Kevin JudiceExecutive officerApr 2010
John C. DoyleExecutive officerApr 2010
John F. HollwayExecutive officerApr 2010
Jon B. BrussExecutive officerApr 2010
Alan B. ColowickDirectorMay 2017
Bryan E. RobertsDirectorMay 2017
Gregory W. SteaDirectorMay 2017
Halley E. GilbertDirectorMay 2017
John C. DoyleDirectorMay 2017
John W. SmitherDirectorMay 2017
Kenneth J. HillanDirectorMay 2017
Kent E. LiegingerDirectorMay 2017
Michael C. FischbachDirectorMay 2017
Christopher T. WalshDirectorJun 2016
Kent C. LiegingerDirectorJun 2016
Bryan J. RobertsDirectorMar 2013
Camille J. SamuelsDirectorMar 2013
Christopher J. WalshDirectorMar 2013
John J. DoyleDirectorMar 2013
Robert J. MoreDirectorMar 2013
Scott J. RocklageDirectorMar 2013
Troy J. CoxDirectorMar 2013
Camille D. SamuelsDirectorApr 2010
Christopher D. WalshDirectorApr 2010
J. Kevin JudiceDirectorApr 2010
Kenneth E. NussbacherDirectorApr 2010
Robert D. MoreDirectorApr 2010
Scott E. RocklageDirectorApr 2010